BLISS GVS PHARMA Fact Sheet, BLISS GVS PHARMA Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BLISS GVS PHARMA Fact Sheet    (BLCH)


Watch: Predict Stock's Next Move Using Volumes


Here is the latest financial fact sheet of BLISS GVS PHARMA. For more details, see the BLISS GVS PHARMA quarterly results and BLISS GVS PHARMA share price and chart. For a sector overview, read our pharmaceuticals sector report.

BLISS GVS PHARMA Price History

Price Rs 111.0
Mkt Cap Rs m 11,473
Vol '000 15.6
P/E X 15.5
P/CF X 10.6
EPS (TTM) Rs 7.2
% ch % -0.1
No. of shares m 103.36
% ch week % -1.3
% ch 1-mth % 1.2
% ch 12-mth % 4.6
52 week H/L Rs 224.0/91.5
(As on Jul 23, 2021 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

BLISS GVS PHARMA Financials

No. of Mths
Year Ending
12
Mar-16
*
12
Mar-17
*
12
Mar-18
*
12
Mar-19
*
12
Mar-20
*
5-Yr Chart
Click to enlarge
BLISS GVS PHARMA EQUITY SHARE DATA
High Rs211188230225184 
Low Rs1087912912574 
Sales per share (Unadj.) Rs52.877.078.987.166.8 
Earnings per share (Unadj.) Rs9.710.98.612.39.2 
Diluted earnings per shareRs9.710.98.612.39.2 
Cash flow per share (Unadj.) Rs11.012.910.713.110.5 
Dividends per share (Unadj.) Rs0.500.601.001.000.50 
Adj. dividends per shareRs0.500.601.001.000.50 
Dividend yield (eoy) %0.30.40.60.60.4 
Book value per share (Unadj.) Rs40.047.252.062.671.3 
Adj. book value per shareRs39.947.151.962.571.2 
Shares outstanding (eoy) m103.15103.15103.15103.15103.15 
Bonus / Rights / Conversions  ----- 
Price / Sales ratio x3.01.72.32.01.9 
Avg P/E ratio x16.412.220.914.213.9 
P/CF ratio (eoy) x14.510.416.813.312.3 
Price / Book Value ratio x4.02.83.52.81.8 
Dividend payout %5.15.511.68.15.4 
Avg Mkt Cap Rs m16,45713,75718,51518,03513,283 
No. of employees `000NANANANANA 
Total wages/salary Rs m337614692423537 
Avg. sales/employee Rs ThNMNMNMNMNM 
Avg. wages/employee Rs ThNMNMNMNMNM 
Avg. net profit/employee Rs ThNMNMNMNMNM 
BLISS GVS PHARMA INCOME DATA
Net Sales Rs m5,4437,9458,1418,9866,893 
Other income Rs m244125265376371 
Total revenues Rs m5,6868,0708,4079,3627,264 
Gross profit Rs m1,5572,0271,6291,5761,098 
Depreciation Rs m13320121489126 
Interest Rs m1861972284454 
Profit before tax Rs m1,4821,7541,4531,8191,290 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m480627566553337 
Profit after tax Rs m1,0011,1278871,267953 
Gross profit margin %28.625.520.017.515.9 
Effective tax rate %32.435.839.030.426.1 
Net profit margin %18.414.210.914.113.8 
BLISS GVS PHARMA BALANCE SHEET DATA
Current assets Rs m5,8305,6596,8746,9357,729 
Current liabilities Rs m3,7904,3712,9942,0702,322 
Net working cap to sales %37.516.247.754.178.5 
Current ratio x1.51.32.33.33.3 
Inventory Days Days38681688 
Debtors Days Days202117134187290 
Net fixed assets Rs m2,9124,5701,7262,1142,561 
Share capital Rs m103103103103103 
"Free" reserves Rs m4,0234,7635,2596,3577,253 
Net worth Rs m4,1264,8665,3626,4607,356 
Long term debt Rs m38225659325372 
Total assets Rs m8,74210,2298,6009,04910,290 
Interest coverage x9.09.97.442.224.8 
Debt to equity ratio x0.10.100.10.1 
Sales to assets ratio x0.60.80.91.00.7 
Return on assets %13.612.913.014.59.8 
Return on equity %24.323.216.519.612.9 
Return on capital %37.038.131.027.517.4 
Exports to sales %00000 
Imports to sales %1.34.1000 
Exports (fob) Rs m00000 
Imports (cif) Rs m68326000 
Fx inflow Rs m3,0253,0692,60803,845 
Fx outflow Rs m3945062560426 
Net fx Rs m2,6322,5632,35303,419 
BLISS GVS PHARMA CASH FLOW
From Operations Rs m 1,129 2,895 176 400 453 
From Investments Rs m -498 -2,312 561 -735 -489 
From Financial Activity Rs m -403 -101 -760 168 -38 
Net Cashflow Rs m 225 474 429 -219 3 
* Results Consolidated
Source: Accord Fintech, Equitymaster

Share Holding

Indian Promoters 33.2%
Foreign collaborators 0.0%
Indian inst/Mut Fund 28.0%
FIIs 21.2%
ADR/GDR 0.0%
Free float 66.8%
Shareholders 39,999
Pledged promoter(s) holding 0.0%
 

Company Information

REGD OFF 102 Hyde Park, Saki Vihar Road, Andheri (East), Mumbai - 400072
E-MAIL info@blissgvs.com WEB http://www.blissgvs.com
TEL 022-42160000 FAX 022-28563930
SECTOR PHARMACEUTICALS GROUP Private sector
TR AGENT Universal Capital Securities Pvt. Ltd, (Formerly Mondkar Computers Pvt Ltd) 21 Shakil Niwas, Opp. Satya Saibaba Temple Mahakali Caves Road, Andheri (E)
YEAR OF INC: 1984 BSE CODE: 506197 FV (Rs): 1 DIV YIELD (%): 0.4

More Pharmaceuticals Company Fact Sheets:   PATIDAR BUILDCON  NARAYANA HRUDAYALAYA  HESTER BIOSCIENCES  SHALBY   MESCO PHARMA  

Compare BLISS GVS PHARMA With:   PATIDAR BUILDCON  NARAYANA HRUDAYALAYA  HESTER BIOSCIENCES  SHALBY   MESCO PHARMA  




Today's Market

Sensex Ends 139 Points Higher; ICICI Bank, Wipro and ITC Among Top Nifty Gainers(Closing)

Indian share markets witnessed positive trading activity throughout the day today and ended higher.

Views on news

BLISS GVS PHARMA Announces Quarterly Results (4QFY21); Net Profit Up 46.3% (Quarterly Result Update)

Jul 9, 2021 | Updated on Jul 9, 2021

For the quarter ended March 2021, BLISS GVS PHARMA has posted a net profit of Rs 82 m (up 46.3% YoY). Sales on the other hand came in at Rs 1 bn (up 10.2% YoY). Read on for a complete analysis of BLISS GVS PHARMA's quarterly results.

Why Did Pharma Stocks Surge? (Views On News)

Jul 17, 2021

A look into the factors contributing to the rally in pharma stocks.

Bajaj Healthcare Rallies 11% on DRDO Nod to Manufacture Oral Covid Drug (Views On News)

Jul 8, 2021

Bajaj Healthcare has more than doubled investors' wealth in the year 2021 so far. The counter has delivered over 240% return in the last one year.

Aurobindo Pharma Rallies on Sale of Injectables Unit to Subsidiary (Views On News)

Jul 2, 2021

Here's why the company sold its business unit to Eugia Pharma Specialities.

KIMS Shares Make Strong Debut Listing at a 22% Premium (Views On News)

Jun 28, 2021

KIMS shares pare gains after making a strong debut on the exchanges.

More Views on News

Most Popular

A 25 Bagger Indian Stock at the Centre of the Global Semiconductor Chip Shortage (Profit Hunter)

Jul 13, 2021

One technology company in India is grossly underrated despite its dominant role in semiconductor chip designing.

RBI Opens a New Market for Investors (Fast Profits Daily)

Jul 16, 2021

You now have a new way to create wealth. Grab it with both hands.

OPEC is Dying! RIP OPEC (Fast Profits Daily)

Jul 13, 2021

Why the global oil cartel is unravelling and how India stands to gain.

Top 4 Companies that Are Strong Monopolies (Views On News)

Jul 10, 2021

A close look at the top 4 companies with a dominant position in their industry.

A Better Way than the Zomato IPO to Play the Food Delivery Megatrend (Profit Hunter)

Jul 14, 2021

A unique backdoor way of making big profits from smallcap companies.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2021
Get our special report Multibagger Stocks Guide (2021 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK BLISS GVS PHARMA

  • Track your investment in BLISS GVS PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON BLISS GVS PHARMA

BLISS GVS PHARMA 8-QTR ANALYSIS

COMPARE BLISS GVS PHARMA WITH

MARKET STATS